• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
Infect Immun. Apr 1977; 16(1): 54–59.
PMCID: PMC421487

Passive immunity to feline leukemia: evaluation of immunity from dams naturally infected and experimentally vaccinated.

Abstract

Antibodies against feline leukemia virus (FeLV) and the feline oncornavirus-associated cell membrane antigen (FOCMA) were transferred from pregnant cats to their suckling kittens. All of these kittens were protected against infection and oncogenesis by virulent FeLV when challenged at 2 weeks of age. Suckling kittens acquired 25 to 100% of maternal virus-neutralizing and FOCMA titers by 3 days of age, and titers underwent linear decay to undetectable levels by 2 to 3 months of age. FOCMA antibody in dams and kittens was identified as immunoglobulin G (IgG) by use of goat anti-human IgG serum, which cross-reacts with feline IgG in the indirect membrane immunofluorescence test for FOCMA antibody. In an attempt to induce protective maternal antibody by vaccination, 10 pregnant cats were immunized by three to five weekly intramuscular injections with purified FeLV inactivated by ultraviolet irradiation. After the course of immunization, neither virus-neutralizing nor FOCMA antibody was detectable in the dams or in 19 kittens born to these cats. When these kittens were challenged with FeLV at 2 weeks of age, 18 of 19 developed persistent viremia and FeLV-related disease.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Essex M. Horizontally and vertically transmitted oncornaviruses of cats. Adv Cancer Res. 1975;21:175–248. [PubMed]
  • Essex M, Klein G, Snyder SP, Harrold JB. Antibody to feline oncornavirus-associated cell membrane antigen in neonatal cats. Int J Cancer. 1971 Nov 15;8(3):384–390. [PubMed]
  • Essex M, Sliski A, Hardy WD, Jr, Cotter SM. Immune response to leukemia virus and tumor-associated antigens in cats. Cancer Res. 1976 Feb;36(2 Pt 2):640–645. [PubMed]
  • Essex M, Snyder SP. Feline oncornavirus-associated cell membrane antigen. I. Serologic studies with kittens exposed to cell-free materials from various feline fibrosarcomas. J Natl Cancer Inst. 1973 Sep;51(3):1007–1012. [PubMed]
  • Essex M, Snyder SP, Klein G. Relationship between humoral antibodies and the failure to develop progressive tumors in cats injected with feline sarcoma virus (FSV). Bibl Haematol. 1973;39:771–777. [PubMed]
  • Fischinger PJ, Blevins CS, Nomura S. Simple, quantitative assay for both xenotropic murine leukemia and ecotropic feline leukemia viruses. J Virol. 1974 Jul;14(1):177–179. [PMC free article] [PubMed]
  • FRIEND C. Immunological relationships of a filterable agent causing a leukemia in adult mice. I. The neutralization of infectivity by specific antiserum. J Exp Med. 1959 Feb 1;109(2):217–228. [PMC free article] [PubMed]
  • Hardy WD, Jr, Hirshaut Y, Hess P. Detection of the feline leukemia virus and other mammalian oncornaviruses by immunofluorescence. Bibl Haematol. 1973;39:778–799. [PubMed]
  • Hardy WD, Jr, Old LJ, Hess PW, Essex M, Cotter S. Horizontal transmission of feline leukaemia virus. Nature. 1973 Aug 3;244(5414):266–269. [PubMed]
  • Hoover EA, Olsen RG, Hardy WD, Jr, Schaller JP, Mathes LE. Feline leukemia virus infection: age-related variation in response of cats to experimental infection. J Natl Cancer Inst. 1976 Aug;57(2):365–369. [PubMed]
  • Ioachim HL, Gimovsky ML, Keller SE, Gross L. Maternal vaccination with formalin-inactivated Gross lymphoma virus in rats and transfer of immunity to offspring. Proc Soc Exp Biol Med. 1973 Nov;144(2):376–379. [PubMed]
  • Jarrett W, Jarrett O, Mackey L, Laird H, Hardy W, Jr, Essex M. Horizontal transmission of leukemia virus and leukemia in the cat. J Natl Cancer Inst. 1973 Sep;51(3):833–841. [PubMed]
  • Jarrett W, Jarrett O, Mackey L, Laird H, Hood C, Hay D. Vaccination against feline leukaemia virus using a cell membrane antigen system. Int J Cancer. 1975 Jul 15;16(1):134–141. [PubMed]
  • Kawakami TG, Theilen GH, Dungworth DL, Munn RJ, Beall SG. "C"-type viral particles in plasma of cats with feline leukemia. Science. 1967 Nov;158(3804):1049–1050. [PubMed]
  • Mirand EA, Grace JT, Buffett RF. Passive and active immunity to Friend virus disease. Nature. 1966 Feb 12;209(5024):696–698. [PubMed]
  • Olsen RG, Hoover EA, Mathes LE, Heding L, Schaller JP. Immunization against feline oncarnavirus disease using a killed tumor cell vaccine. Cancer Res. 1976 Oct;36(10):3642–3646. [PubMed]
  • Sarma PS, Log T. Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests. Virology. 1973 Jul;54(1):160–169. [PubMed]
  • Schaller JP, Essex M, Yohn DS, Olsen RG. Feline oncornavirus-associated cell membrane antigen. V. Humoral immune response to virus and cell membrane antigens in cats inoculated with Gardner-Arnstein feline sarcoma virus. J Natl Cancer Inst. 1975 Dec;55(6):1373–1378. [PubMed]
  • Schaller JP, Olsen RG. Determination of subgroup-specific feline oncornavirus-neutralizing antibody. Infect Immun. 1975 Dec;12(6):1405–1410. [PMC free article] [PubMed]
  • Schultz RD, Scott FW, Duncan JR, Gillespie JH. Feline immunoglobulins. Infect Immun. 1974 Feb;9(2):391–393. [PMC free article] [PubMed]
  • Scott FW, Csiza CK, Gillespie JH. Maternally derived immunity to feline panleukopenia. J Am Vet Med Assoc. 1970 Feb 15;156(4):439–453. [PubMed]
  • Snyder SP, Dungworth DL. Pathogenesis of feline viral fibrosarcomas: dose and age effects. J Natl Cancer Inst. 1973 Sep;51(3):793–798. [PubMed]
  • Theilen GH, Kawakami TG, Rush JD, Munn RJ. Replication of cat leukemia virus in cell suspension cultures. Nature. 1969 May 10;222(5193):589–590. [PubMed]
  • Yohn DS, Olsen RG, Schaller JP, Hoover EA, Mathes LE, Heding L, Davis GW. Experimental oncornavirus vaccines in the cat. Cancer Res. 1976 Feb;36(2 Pt 2):646–651. [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...